These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1309064)

  • 1. Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor- and kringle 1-domains.
    Emeis JJ; Verheijen JH
    Ann N Y Acad Sci; 1992 Dec; 667():421-3. PubMed ID: 1309064
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor--and kringle one-domains.
    Emeis JJ; Verheijen JH
    Arzneimittelforschung; 1992 Mar; 42(3):358-62. PubMed ID: 1497699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis with an Escherichia coli-produced recombinant plasminogen activator (BM 06.022) in the rabbit model of jugular vein thrombosis.
    Martin U; Fischer S; Kohnert U; Opitz U; Rudolph R; Sponer G; Stern A; Strein K
    Thromb Haemost; 1991 May; 65(5):560-4. PubMed ID: 1908140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic properties of human tissue-type plasminogen activator, single-chain urokinase-type plasminogen activator, and synergistic combinations in venous thrombosis models in dogs and rabbits.
    Spriggs DJ; Stassen JM; Hashimoto Y; Collen D
    Blood; 1989 Apr; 73(5):1207-12. PubMed ID: 2495034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative time course of thrombolysis induced by intravenous boluses and infusion of staphylokinase and tissue plasminogen activator in a rabbit arterial thrombosis model.
    Helft G; Bara L; Bloch MF; Samama MM
    Blood Coagul Fibrinolysis; 1998 Jul; 9(5):411-7. PubMed ID: 9712289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of pulse-sprayed recombinant tissue plasminogen activator for deep venous thrombosis.
    Horne MK; Chang R
    Thromb Res; 2003; 111(1-2):111-4. PubMed ID: 14644088
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
    Collen D; Stassen JM; De Cock F
    Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA.
    Heeremans JL; Prevost R; Bekkers ME; Los P; Emeis JJ; Kluft C; Crommelin DJ
    Thromb Haemost; 1995 Mar; 73(3):488-94. PubMed ID: 7667833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thrombolytic effect of human tissue-type plasminogen activator on the experimental thrombosis in rabbit.
    Masunaga H; Arisawa H; Katayama S
    Nihon Juigaku Zasshi; 1988 Dec; 50(6):1232-8. PubMed ID: 3150020
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolytic effect after sequential double-bolus administration of tissue plasminogen activator and urokinase-fibrinogen conjugate into dogs with venous thrombosis.
    Maksimenko AV; Tischenko EG; Golubykh VL
    Ann N Y Acad Sci; 1998 Dec; 864():409-17. PubMed ID: 9928118
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of prosthetic tricuspid valve thrombosis with short-course recombinant tissue-type plasminogen activator.
    Tischler MD; Lee RT; Kirshenbaum JM
    Am Heart J; 1990 Oct; 120(4):975-7. PubMed ID: 2121011
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the finger domain.
    Yahara H; Matsumoto K; Maruyama H; Nagaoka T; Ikenaka Y; Yajima K; Fukao H; Ueshima S; Matsuo O
    Thromb Haemost; 1992 Dec; 68(6):672-7. PubMed ID: 1287881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic activity of two chimeric recombinant plasminogen activators (FK2tu-PA and K2tu-PA) in rabbits.
    Agnelli G; Pascucci C; Colucci M; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1992 Sep; 68(3):331-5. PubMed ID: 1440500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo.
    Biemond BJ; Friederich PW; Koschinsky ML; Levi M; Sangrar W; Xia J; Büller HR; ten Cate JW
    Circulation; 1997 Sep; 96(5):1612-5. PubMed ID: 9315555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in systemic fibrinolysis and blood coagulation parameters in local thrombolysis with tissue plasminogen activator (rt-PA)].
    Klein P; Roth FJ; Rieger H; Popov-Cenic S
    Vasa; 1992; 21(3):249-52. PubMed ID: 1529628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid localization of indium-111-labeled inhibited recombinant tissue plasminogen activator in a rabbit thrombosis model.
    Butler SP; Kader KL; Owen J; Wang TS; Fawwaz RA; Alderson PO
    J Nucl Med; 1991 Mar; 32(3):461-7. PubMed ID: 1900886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional fibrinolysis using tissue plasminogen activator in 2 cases of acute thrombosis of the renal artery.
    Giorgetti PL; Lovaria A; Saccheri S; Arpesani A; Rignano A; Bortolani EM; Galimberti M
    Panminerva Med; 1991; 33(4):180-4. PubMed ID: 1806875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remaining perspectives of mutant and chimeric plasminogen activators.
    Lijnen HR; Collen D
    Ann N Y Acad Sci; 1992 Dec; 667():357-64. PubMed ID: 1309056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.